MOODY ALDRICH PARTNERS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
MOODY ALDRICH PARTNERS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$1,901,000
-5.5%
16,651
+4.1%
0.49%
-14.0%
Q1 2019$2,011,000
-36.8%
15,994
-31.8%
0.56%
-45.9%
Q4 2018$3,182,000
-44.5%
23,446
+12.3%
1.04%
-36.7%
Q3 2018$5,729,000
+4.6%
20,871
-21.0%
1.65%
-15.2%
Q2 2018$5,476,00026,4321.95%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders